Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-109203
Filing Date
2025-11-12
Accepted
2025-11-12 16:10:24
Documents
63
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0263576-10q_china.htm   iXBRL 10-Q 610171
2 CERTIFICATION ea026357601ex31-1_china.htm EX-31.1 10077
3 CERTIFICATION ea026357601ex31-2_china.htm EX-31.2 10025
4 CERTIFICATION ea026357601ex32-1_china.htm EX-32.1 5254
  Complete submission text file 0001213900-25-109203.txt   4163570

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20250930.xsd EX-101.SCH 38944
6 XBRL CALCULATION FILE cphi-20250930_cal.xml EX-101.CAL 41421
7 XBRL DEFINITION FILE cphi-20250930_def.xml EX-101.DEF 193468
8 XBRL LABEL FILE cphi-20250930_lab.xml EX-101.LAB 383138
9 XBRL PRESENTATION FILE cphi-20250930_pre.xml EX-101.PRE 218792
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0263576-10q_china_htm.xml XML 403988
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 251472777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)